TNFα played a role in induction of Akt and MAPK signals in ameloblastoma

Oral Oncology

Volumn 41, Issue 4, 2005, Pages 375-382

  Hendarmin, Laifa ^a   Sandra, Ferry ^a   Nakao, Yu ^a   Ohishi, Masamichi ^a   Nakamura, Norifumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Akt; AM 1; Ameloblastoma; MAPK; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SERINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TYROSINE; AKT1 PROTEIN, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; TUMOR PROTEIN;

AMELOBLASTOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ENZYME IMMUNOASSAY; JAW TUMOR; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMELOBLASTOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOENZYME TECHNIQUES; JAW NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 15244354009     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.09.014     Document Type: Article

References (26)

1. R.B. Lucas Ameloblastoma R.A. Cawson W.H. Binnie P.M. Speight A.W. Barret J.M. Wright P. Thorogood Lucas's pathology of tumors of the oral tissues 5th ed. 1998 Churchill Livingstone London 25 44
2. I.R.H. Kramer, J.J. Pinborg, and M. Shear World Health Organization international histological classification of tumours. Histological typing of odontogenic tumours 2nd ed. 1992 Springer-Verlag Berlin
3. F. Sandra, N. Nakamura, T. Mitsuyasu, Y. Shiratsuchi, and M. Ohishi Two relatively distinct patterns of ameloblastoma: an anti-apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre) Histopathology 39 1 2001 93 98
4. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter Molecular biology of the cell 4th ed. 2002 Garland Science New York p. 983-1026
5. U. Gaur, and B.B. Aggarwal Regulation of proliferation, survival and apoptosis by members of the TNF family Biochem Pharmacol 66 8 2003 1403 1408
6. A. Nitta, W.H. Zheng, and R. Quirion Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3K/Akt pathway J Neurosci Res 76 1 2004 98 103
7. F. Sandra, H. Harada, N. Nakamura, and M. Ohishi Midkine induced growth of ameloblastoma through MAPK and Akt pathways Oral Oncol 40 3 2004 274 280
8. M. Ozen, D. Giri, F. Ropiquet, A. Mansukhani, and M. Ittmann Role of fibroblast growth factor receptor signaling in prostate cancer cell survival J Natl Cancer Inst 93 23 2001 1783 1790
9. S. Gupta A decision between life and death during TNF-α-induced signaling J Clin Immunol 22 4 2002 185 194
10. P. Vandenabeele, W. Declercq, R. Beyaert, and W. Fiers Two tumour necrosis factor receptors: structure and function Trends Cell Biol 5 10 1995 392 399
11. V. Baud, and M. Karin Signal transduction by tumor necrosis factor and its relatives Trends Cell Biol 11 9 2001 372 377
12. G. Chen, and D.V. Goeddel TNF-R1 signaling: a beautiful pathway Science 296 5573 2002 1634 1635
13. O.N. Ozes, L.D. Mayo, J.A. Gustin, S.R. Pfeffer, L.M. Pfeffer, and D.B. Donner NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase Nature 401 6748 1999 82 85
14. S. Sato, N. Fujita, and T. Tsuruo Involvement of 3-phosphoinositide- dependent protein kinase-1 in the MEK/MAPK signal transduction pathway J Biol Chem 279 32 2004 33759 33767
15. Y. Kubota, S. Nitta, S. Oka, S. Nakagawa, T. Ninomiya, and K. Shirasuna Discrimination of ameloblastomas from odontogenic keratocysts by cytokine levels and gelatinase species of the intracystic fluids J Oral Pathol Med 30 7 2001 421 427
16. P. Pripatnanont, Y. Song, M. Harris, and S. Meghji In situ hybridisation and immunocytochemichal localisation of osteolytic cytokines and adhesion molecules in ameloblastomas J Oral Pathol Med 27 10 1998 496 500
17. H. Harada, T. Mitsuyasu, and N. Nakamura Establishment of ameloblastoma cell line, AM-1 J Oral Pathol Med 27 5 1998 207 212
18. F. Balkwill Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13 2 2002 135 141
19. A.J. Karayiannakis, K.N. Syrigos, A. Polychronidis, M. Pitiakoudis, A. Bounovas, and K. Simopoulos Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients Anticancer Res 21 2B 2001 1355 1358
20. N. Yoshida, S. Ikemoto, and K. Narita Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma Br J Cancer 86 9 2002 1396 1400
21. R.D. Leek, R. Landers, S.B. Fox, F. Ng, A.L. Harris, and C.E. Lewis Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma Br J Cancer 77 12 1998 2246 2251
22. J. Pfitzenmaier, R. Vessella, C.S. Higano, J.L. Noteboom, D. Wallace Jr., and E. Corey Elevation of cytokine levels in cachectic patients with prostate carcinoma Cancer 97 5 2003 1211 1216
23. G.M. Anderson, M.T. Nakada, and M. DeWitte Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer Curr Opin Pharmacol 4 4 2004 314 320
24. F. Sandra, T. Mitsuyasu, N. Nakamura, Y. Shiratsuchi, and M. Ohishi Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma Oral Oncol 37 2 2001 193 198
25. F. Sandra, N. Nakamura, T. Kanematsu, M. Hirata, and M. Ohishi The role of MDM2 in the proliferative activity of ameloblastoma Oral Oncol 38 2 2002 153 157
26. F. Sandra, N.A. Matsuki, and H. Takeuchi TNF inhibited the apoptosis by activation of Akt serine/threonine kinase in the human head and neck squamous cell carcinoma Cell Signal 14 9 2002 771 778